Artivion (AORT) news
Recent news
Artivion Q2 adjusted EPS USD 0.13 vs. IBES estimate USD 0.01
AInvest Wire · Aug 6, 2026Artivion 2Q adj. EBITDA $26.4M, est. $21.7M
AInvest Wire · Aug 6, 2026Artivion completes acquisition of Endospain
AInvest Wire · May 18, 2026Artivion closes purchase of Endospain
Artivion, Inc. (NYSE: AORT) has exercised its option to acquire Endospan Ltd., an Israeli-based developer of the NEXUS Aortic Arch Stent Graft System, for an upfront purchase price of $135 million, net of previously extended loans. The acquisition is expected to close in the second quarter of 2026,…
AInvest Wire · May 18, 2026Artivion: Incident involved acquisition and encryption of files
Artivion: Incident involved acquisition and encryption of files The recent Artivion data incident, which involved the acquisition and encryption of files, has raised concerns about the importance of preserving digital evidence in the wake of cyber attacks. As the world becomes increasingly reliant…
AInvest Wire · Dec 9, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.